POLICY

CAD ACS & AMI

QUALITY

Workshop

CANADIAN CARDIOVASCULAR SOCIETY ST-ELEVATION MYOCARDIAL INFARCTION GUIDELINES: ARE WE COMPLIANT ACROSS CANADA? DO WE NEED TO DEVELOP AND REPORT NEW QUALITY INDICATORS BASED ON THESE GUIDELINES?

Chair(s)

• Ata-ur-Rehman Q.

  Ata-ur-Rehman Quraishi, MBBS, FCPS, FACC

  Head, Division of Cardiology
  QEII Health Sciences Centre

Co-Chair(s)

• 

  Karin Humphries, MBA, DSc, FAHA

  Scientific Director
  Centre for Improved Cardiovascular Health (ICVHealth)
  University of British Columbia

Presenter(s)

• 

  Robert Welsh, MD, FRCPC, FESC, FACC, FAHA

  Zone Clinical Department Head, Clinical Sciences and Interventional Cardiologist
  Mazankowski Alberta Heart Institute
  University of Alberta
• Akshay B.

  Akshay Bagai, MD, FRCPC, MHS

  Interventional Cardiologist
• 

  Laurie Lambert, MPH, PhD

  Principal scientist
  Institut national d'excellence en santéet en services sociaux (INESSS)

This workshop will present results of current CCS priority quality indicators for PCI, as well as available results for AMI and STEMI mortality across Canada using CIHI reports. These results will be considered in light of the new CCS STEMI guidelines in order to initiate discussion concerning the need for development and measurement of new or revised quality indicators for Canada.

 

Learning Objectives

At the conclusion of this session, participants will be able to:

• discuss the quality of care for different patient populations in Canada;
• discuss the challenges of quality indicator measurement for PCI and STEMI in Canada, and how to measure adherence to Canada's new STEMI guidelines; and
• discuss important elements of a good quality indicator.